Literature DB >> 22995897

How many dendritic cells are required to initiate a T-cell response?

Susanna Celli1, Mark Day, Andreas J Müller, Carmen Molina-Paris, Grant Lythe, Philippe Bousso.   

Abstract

T-cell activation in lymph nodes relies on encounters with antigen (Ag)-bearing dendritic cells (DCs) but the number of DCs required to initiate an immune response is unknown. Here we have used a combination of flow cytometry, 2-photon imaging, and computational modeling to quantify the probability of T cell-DC encounters. We calculated that the chance for a T cell residing 24 hours in a murine popliteal lymph nodes to interact with a DC was 8%, 58%, and 99% in the presence of 10, 100, and 1000 Ag-bearing DCs, respectively. Our results reveal the existence of a threshold in DC numbers below which T-cell responses fail to be elicited for probabilistic reasons. In mice and probably humans, we estimate that a minimum of 85 DCs are required to initiate a T-cell response when starting from precursor frequency of 10(-6). Our results have implications for the rational design of DC-based vaccines.

Entities:  

Mesh:

Year:  2012        PMID: 22995897     DOI: 10.1182/blood-2012-01-408260

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

Review 1.  Applications of mechanistic modelling to clinical and experimental immunology: an emerging technology to accelerate immunotherapeutic discovery and development.

Authors:  L V Brown; E A Gaffney; J Wagg; M C Coles
Journal:  Clin Exp Immunol       Date:  2018-09       Impact factor: 4.330

2.  A spatial model of the efficiency of T cell search in the influenza-infected lung.

Authors:  Drew Levin; Stephanie Forrest; Soumya Banerjee; Candice Clay; Judy Cannon; Melanie Moses; Frederick Koster
Journal:  J Theor Biol       Date:  2016-02-23       Impact factor: 2.691

3.  An in silico model of cytotoxic T-lymphocyte activation in the lymph node following short peptide vaccination.

Authors:  Liam V Brown; Eamonn A Gaffney; Jonathan Wagg; Mark C Coles
Journal:  J R Soc Interface       Date:  2018-03       Impact factor: 4.118

Review 4.  Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.

Authors:  Sébastien Anguille; Eva Lion; Johan Van den Bergh; Heleen H Van Acker; Yannick Willemen; Evelien L Smits; Viggo F Van Tendeloo; Zwi N Berneman
Journal:  Hum Vaccin Immunother       Date:  2013-06-18       Impact factor: 3.452

5.  Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers.

Authors:  Vivek Subbiah; Ravi Murthy; David S Hong; Robert M Prins; Chitra Hosing; Kyle Hendricks; Deepthi Kolli; Lori Noffsinger; Robert Brown; Mary McGuire; Siquing Fu; Sarina Piha-Paul; Aung Naing; Anthony P Conley; Robert S Benjamin; Indreshpal Kaur; Marnix L Bosch
Journal:  Clin Cancer Res       Date:  2018-07-17       Impact factor: 12.531

6.  Naturally circulating dendritic cells to vaccinate cancer patients.

Authors:  Kalijn F Bol; Jurjen Tel; I Jolanda M de Vries; Carl G Figdor
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

7.  Bringing statistics up to speed with data in analysis of lymphocyte motility.

Authors:  Kenneth Letendre; Emmanuel Donnadieu; Melanie E Moses; Judy L Cannon
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

8.  Reducing cell number improves the homing of dendritic cells to lymph nodes upon intradermal vaccination.

Authors:  Erik Hjg Aarntzen; Mangala Srinivas; Gerty Schreibelt; Arend Heerschap; Cornelius Ja Punt; Carl G Figdor; Wim J Oyen; I Jolanda M de Vries
Journal:  Oncoimmunology       Date:  2013-04-30       Impact factor: 8.110

9.  BCG Skin Infection Triggers IL-1R-MyD88-Dependent Migration of EpCAMlow CD11bhigh Skin Dendritic cells to Draining Lymph Node During CD4+ T-Cell Priming.

Authors:  Vishnu Priya Bollampalli; Lívia Harumi Yamashiro; Xiaogang Feng; Damiën Bierschenk; Yu Gao; Hans Blom; Birgitta Henriques-Normark; Susanne Nylén; Antonio Gigliotti Rothfuchs
Journal:  PLoS Pathog       Date:  2015-10-06       Impact factor: 6.823

Review 10.  The Timing of T Cell Priming and Cycling.

Authors:  Reinhard Obst
Journal:  Front Immunol       Date:  2015-11-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.